Interaction of Quercus infectoria Gall's Extract and Vancomycin Against Staphylococcus aureus with Reduce Susceptibility to Vancomycin

被引:0
|
作者
Jaffar, Norzawani [1 ]
Basri, Dayang Fredalina [1 ]
Zin, Noraziah M. [1 ]
机构
[1] Univ Kebangsaan Malaysia, Fak Sains Kesihatan Bersekutu, Kuala Lumpur 50300, Malaysia
来源
SAINS MALAYSIANA | 2011年 / 40卷 / 11期
关键词
Anti-MRSA; Quercus infectoria gall; vancomycin; METHICILLIN-RESISTANT; GROWTH;
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Methicillin-resistant Staphylococcus aureus (MRSA) is a versatile pathogen widespread, and tend to be multi-resistant towards almost all of currently available antibiotics. The gall of Quercus infectoria or locally known as manjakani in Malaysia was known to have antibacterial activity. The aim of this study was to evaluate the interaction effect of Q. infectoria gall extract with vancomycin against five MRSA strains and two Vancomycin Intermediate Staphylococcus aureus (VISA) strains. The extracts were prepared using acetone, methanol and aqueous. The microbroth serial dilution technique was employed using 96-well microtiter plate for determination of MIC values. The effect of interaction between Q. infectoria gall extract and vancomycin was evaluated using the checkerboard method to obtain the Fractional inhibitory concentration (FIC) index value. The extracts combination with vancomycin displayed synergism for acetone extract against MRSA ATCC 43300 (0.3124), Sa7 (0.3750) and VISA U9495 (0.3750), while aqueous extract were synergistic against MRSA Sa7 (0.4167) and VISA U9495 (0.3958) and N316 (0.5000). On the other hand, vancomycin combination with methanol only exhibited synergistic effect towards ATCC 49476 (0.3750) but additive against 6 other strains tested. This interaction effect showed their potential and importance in development or modification of drugs against MRSA.
引用
收藏
页码:1237 / 1241
页数:5
相关论文
共 50 条
  • [41] Screening for Staphylococcus aureus with a reduced susceptibility to vancomycin in:: a Belgian hospital
    Piérard, D
    Vandenbussche, H
    Verschraegen, I
    Lauwers, S
    PATHOLOGIE BIOLOGIE, 2004, 52 (08): : 486 - 488
  • [42] Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin
    Sakoulas, G
    Alder, J
    Thauvin-Eliopouios, C
    Moellering, RC
    Eliopoulos, GM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) : 1581 - 1585
  • [43] Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin
    Oliveira, GA
    Dell'Aquila, AM
    Masiero, RL
    Levy, CE
    Gomes, MS
    Cui, L
    Hiramatsu, K
    Mamizuka, EM
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2001, 22 (07): : 443 - 448
  • [44] Susceptibility to manuka honey of Staphylococcus aureus with varying sensitivities to vancomycin
    Jenkins, Rowena
    Wootton, Mandy
    Howe, Robin
    Cooper, Rose
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 40 (01) : 88 - 89
  • [45] Role of capsular polysaccharides in decreased susceptibility to vancomycin in Staphylococcus aureus
    Jansen, A.
    Szekat, C.
    Wolz, C.
    Goerke, C.
    Bierbaum, G.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 297 : 117 - 117
  • [46] Decreased colony spreading in Staphylococcus aureus with reduced vancomycin susceptibility
    Thaweecheep, Waritsara
    Kaito, Chikara
    Chanawong, Aroonwadee
    Tippayawat, Patcharaporn
    Tavichakorntrakool, Ratree
    Lulitanond, Aroonlug
    SCIENCEASIA, 2024, 50 (05):
  • [47] Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin
    Song, JH
    Hiramatsu, K
    Suh, JY
    Ko, KS
    Ito, T
    Kapi, M
    Kiem, S
    Kim, YS
    Won, SH
    Peck, KR
    Lee, NY
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4926 - 4928
  • [48] Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in Korea
    Kim, HB
    Park, WB
    Lee, KD
    Choi, YJ
    Park, SW
    Oh, MD
    Kim, EC
    Choe, KW
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (06) : 2279 - 2281
  • [49] Reduced Susceptibility to Vancomycin Influences Pathogenicity in Staphylococcus aureus Infection
    Peleg, Anton Y.
    Monga, Divya
    Pillai, Satish
    Mylonakis, Eleftherios
    Moellering, Robert C., Jr.
    Eliopoulos, George M.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (04): : 532 - 536
  • [50] β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA
    Tran, Nikki
    Rybak, Michael J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (06)